Ocular Subcommittee

(The OPTIC Subcommittee was renamed to Ocular Subcommittee in August 2023)

Co-Chairs:

This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it.

Charges: 

- To bring professionals of this highly specialized field together and share experience 

- To map the status of ocular proton therapy worldwide 

- To seek consensus and standardize our clinical procedures

- To address obsoleteness of our facilities on the community level

- To define standards in treatment planning and address discontinuation of Eyeplan

- To develop propose and collaborate in clinical trials

- To collaborate on physics aspects

- Assemble team with names hardest to spell

Recent publication:

Mishra K, Afshar A, Thariat J, Shih H, Scholey J, Daftari I, Kacperek A, Pica A, Hrbacek J, Dendale R, Mazal A, Heufelder J, Char D, Sauerwein W, Weber D, Damato B, Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience, Advances in Radiation Oncology (2020), DOI: https://doi.org/10.1016/j.adro.2020.04.010

PTCOG Ocular Statement: Expert Summary of Current Practices and Future Developments in Ocular Proton Therapy

*******

PTCOG Optic Subcommittee Report, June 2022, PTCOG 60, Miami

PTCOG Optic Subcommittee Meeting Report, PTCOG 61, Madrid